LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 46.22 | 27.76 | 5371 | 4125 | 1.3021 | 1.0745 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 47.93 | 27.76 | 3931 | 4421 | 0.8891 | 0.9681 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 47.93 | 27.76 | 3989 | 4421 | 0.9022 | 0.9721 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 47.93 | 27.76 | 832 | 4421 | 0.1882 | 0.5917 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 47.93 | 27.76 | 5708 | 4421 | 1.2910 | 1.0711 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 49.63 | 27.76 | 4212 | 4818 | 0.8742 | 0.9642 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 49.63 | 27.76 | 4282 | 4818 | 0.8887 | 0.9685 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 49.63 | 27.76 | 981 | 4818 | 0.2036 | 0.6148 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 49.63 | 27.76 | 6107 | 4818 | 1.2675 | 1.0648 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 51.33 | 27.76 | 4577 | 5117 | 0.8945 | 0.9706 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 51.33 | 27.76 | 4635 | 5117 | 0.9058 | 0.9739 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 51.33 | 27.76 | 1059 | 5117 | 0.2070 | 0.6223 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 51.33 | 27.76 | 6475 | 5117 | 1.2654 | 1.0635 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 53.04 | 27.76 | 4815 | 5365 | 0.8974 | 0.9717 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 53.04 | 27.76 | 4874 | 5365 | 0.9084 | 0.9749 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 53.04 | 27.76 | 920 | 5365 | 0.1715 | 0.5856 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 53.04 | 27.76 | 6847 | 5365 | 1.2761 | 1.0652 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 54.74 | 27.76 | 5038 | 5606 | 0.8986 | 0.9723 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 54.74 | 27.76 | 5109 | 5606 | 0.9113 | 0.9759 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 54.74 | 27.76 | 1010 | 5606 | 0.1802 | 0.5989 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 54.74 | 27.76 | 7230 | 5606 | 1.2896 | 1.0675 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 56.45 | 27.76 | 5301 | 5745 | 0.9227 | 0.9792 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 56.45 | 27.76 | 5375 | 5745 | 0.9355 | 0.9828 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 56.45 | 27.76 | 964 | 5745 | 0.1678 | 0.5859 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 56.45 | 27.76 | 7522 | 5745 | 1.3092 | 1.0713 | MN20160318_Q01 | K18 |